Road to market:                                      The path of RUBYnanomed
RUBYnanomed is bringing to the market a non-invasive in vitro diagnostics tool for cancer patient monitoring based on liquid biopsy. During this one hour interactive webinar, we will present the main benefits of the technology, and share insights and progress about bringing a medical device to market. Attendees can expect a first-hand experience in scaling-up a novel microfluidic technology, focusing on partnerships, industrialisation and regulatory roadmap. The session includes the vision from the oncologists and clinicians and from regulatory experts.

The webinar will take place on June 14th at 15:00 WEST (16:00 CEST)

Sign in to Google to save your progress. Learn more
Email *
First name
 *
Last name
 *
Affiliation
 *
Country
 *
Type of Institution
 *
Hereby, I consent to be contacted in the email address provided above to receive information about the event. RUBYnanomed has procedures based on a personal data protection policy that are established in accordance with Regulation (EU) 2016/679 of the European Parliament and of the Council, of 27 April 2016, on the protection of individuals regarding the processing of personal data and on the free movement of such data. *
Required
Submit
Clear form
Never submit passwords through Google Forms.
This content is neither created nor endorsed by Google. - Terms of Service - Privacy Policy

Does this form look suspicious? Report

Google Forms